Eli Lilly Non Current Assets Total Over Time
LLY Stock | USD 734.97 20.94 2.77% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Eli Lilly Performance and Eli Lilly Correlation. Eli |
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.664 | Dividend Share 4.69 | Earnings Share 6.76 | Revenue Per Share 39.919 | Quarterly Revenue Growth 0.26 |
The market value of Eli Lilly is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Non Current Assets Total Analysis
Compare Eli Lilly and related stocks such as Johnson Johnson, Bristol Myers Squibb, and AbbVie Inc Non Current Assets Total Over Time
Select Fundamental2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | 2.2 B | 59.3 B | 75.2 B | 76.3 B | 71.8 B | 73.2 B | 76.2 B | 114.2 B | 106.9 B | 112.5 B | 123.7 B | 121 B | 132.1 B | 114.1 B | 119.8 B |
BMY | 2.5 B | 17.7 B | 26.4 B | 19.7 B | 19.1 B | 21.3 B | 20 B | 18.7 B | 1.8 B | 100.6 B | 88.3 B | 76.1 B | 69.5 B | 63.4 B | 66.6 B |
ABBV | 12.9 B | 12.3 B | 11.7 B | 11.3 B | 11.5 B | 36.7 B | 49.9 B | 49.6 B | 42.4 B | 39.6 B | 126.4 B | 118.6 B | 110.3 B | 101.7 B | 57.7 B |
PFE | 2.3 B | 130.3 B | 124.4 B | 115.9 B | 111.6 B | 123.7 B | 132.7 B | 130.7 B | 109.5 B | 134.7 B | 119.2 B | 121.8 B | 145.9 B | 183.2 B | 192.3 B |
MRK | 2.6 B | 71.9 B | 71.3 B | 70 B | 65.2 B | 72 B | 64.8 B | 63.1 B | 56.8 B | 56.9 B | 63.8 B | 75.4 B | 73.4 B | 74.5 B | 41.1 B |
AMGN | 23.9 M | 21.3 B | 23.1 B | 38.8 B | 34.3 B | 33.1 B | 31.6 B | 30.5 B | 28.8 B | 41.3 B | 41.8 B | 41.8 B | 42.9 B | 66.8 B | 70.2 B |
GILD | 2.1 M | 4 B | 15.2 B | 15.8 B | 16.9 B | 17.8 B | 18.5 B | 28.9 B | 28 B | 30.1 B | 52.6 B | 52.9 B | 47.9 B | 45.7 B | 48 B |
Eli Lilly and related stocks such as Johnson Johnson, Bristol Myers Squibb, and AbbVie Inc Non Current Assets Total description
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
Eli Lilly and | LLY |
ESG InvestingFama & French Classification | |
Location | Indiana; U.S.A |
Exchange | New York Stock Exchange |
USD 734.97
Check out Eli Lilly Performance and Eli Lilly Correlation. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Eli Stock analysis
When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Eli Lilly technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.